NHS chief to retire – but not until next year
Sir David Nicholson has announced that he will retire from the top job in the NHS next year after months of criticism of his managerial role at Mid Staffs.
Read MoreAuthor: Ben Adams
Rawlins ‘burns credibility’ with biotech move
The former chairman of NICE Sir Michael Rawlins has attracted criticism after taking up the position of a board member at US biotech firm Intra-Cellular Therapies.
Read MoreTen UK charities win GSK accolade and cash boost
Ten charities have won GlaxoSmithKline’s IMPACT Awards for 2013 after being recognised for helping the UK with its health and well-being.
Read MoreNICE thumbs up for new Astellas bladder drug
In final draft guidance NICE is recommending Astellas’s Betmiga (mirabegron) for the treatment of overactive bladder syndrome in patients for whom antimuscarinic drugs – the established treatment for the condition – are not suitable.
Read MoreShire’s shenanigans continue; guilty of 10 Code breaches
Shire has once again fallen foul of the ABPI Code of Conduct after using a press release for its Gaucher’s disease drug Vpriv to knock a rival product.
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
